Literature DB >> 8138951

Increased active stress generation of denervated rat intestinal smooth muscle: functional analysis of muscarinic receptor population.

M A Osinski1, P Bass.   

Abstract

The effects of denervation on the active stress production by the longitudinal muscle (LM) layer of rat jejunum were examined. Extrinsic and myenteric denervation of a segment of rat jejunum was accomplished by the serosal application of the cationic surfactant benzyldimethyltetradecylammonium chloride (BAC). Isolated muscle contraction experiments revealed that the LM of the jejunum taken from rats treated with BAC 15 days before developed significantly increased active stress in response to bethanechol and carbachol, but not in response to potassium chloride. No change in -log EC50 values of any of the agonists was observed in the denervated LM layer, although a significant increase in the slope of the carbachol and bethanechol concentration-response curves was observed in the denervated LM. Schild analysis of several muscarinic antagonists revealed a 3-fold increase in the apparent dissociation constant of the M2 antagonist methoctramine in BAC-treated LM. These results suggest that the increased responsiveness of the denervated LM may originate in the muscarinic receptor population of the myocytes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8138951

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  2 in total

1.  Numerical simulation of excitation-contraction coupling in a locus of the small bowel.

Authors:  R N Miftakhov; G R Abdusheva
Journal:  Biol Cybern       Date:  1996-05       Impact factor: 2.086

2.  Effect of ileo-jejunal transposition on ileal longitudinal smooth muscle contractility in vitro in rats.

Authors:  Chikashi Shibata; Yuji Funayama; Kouhei Fukushima; Tatsuya Ueno; Munenori Nagao; Hiroo Naito; Michiaki Unno; Ken-ichi Shiiba; Seiki Matsuno; Iwao Sasaki
Journal:  J Gastrointest Surg       Date:  2004-12       Impact factor: 3.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.